BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17981750)

  • 1. Polymer-drug conjugates: current status and future trends.
    Greco F; Vicent MJ
    Front Biosci; 2008 Jan; 13():2744-56. PubMed ID: 17981750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer conjugates: nanosized medicines for treating cancer.
    Vicent MJ; Duncan R
    Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer--drug conjugates as nano-sized medicines.
    Canal F; Sanchis J; Vicent MJ
    Curr Opin Biotechnol; 2011 Dec; 22(6):894-900. PubMed ID: 21724381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer conjugates as therapeutics: future trends, challenges and opportunities.
    Vicent MJ; Dieudonné L; Carbajo RJ; Pineda-Lucena A
    Expert Opin Drug Deliv; 2008 May; 5(5):593-614. PubMed ID: 18491984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer conjugates as anticancer nanomedicines.
    Duncan R
    Nat Rev Cancer; 2006 Sep; 6(9):688-701. PubMed ID: 16900224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
    Gaspar R; Duncan R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1220-31. PubMed ID: 19682513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.
    Duncan R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1131-48. PubMed ID: 19699249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
    Duncan R; Vicent MJ
    Adv Drug Deliv Rev; 2010 Feb; 62(2):272-82. PubMed ID: 20005271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
    Markovsky E; Baabur-Cohen H; Satchi-Fainaro R
    J Control Release; 2014 Aug; 187():145-57. PubMed ID: 24862318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.
    Kieler-Ferguson HM; Fréchet JM; Szoka FC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):130-8. PubMed ID: 23335566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-drug conjugate therapeutics: advances, insights and prospects.
    Ekladious I; Colson YL; Grinstaff MW
    Nat Rev Drug Discov; 2019 Apr; 18(4):273-294. PubMed ID: 30542076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dawning era of polymer therapeutics.
    Duncan R
    Nat Rev Drug Discov; 2003 May; 2(5):347-60. PubMed ID: 12750738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century.
    Duncan R
    J Drug Target; 2017; 25(9-10):759-780. PubMed ID: 28783978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
    Duncan R; Vicent MJ; Greco F; Nicholson RI
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-responsive polymer-drug conjugates: Design and progress.
    Pang X; Jiang Y; Xiao Q; Leung AW; Hua H; Xu C
    J Control Release; 2016 Jan; 222():116-29. PubMed ID: 26704934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in polymer drug conjugates.
    Sharma R; Singla N; Mehta S; Gaba T; Rawal RK; Rao HS; Bhardwaj TR
    Mini Rev Med Chem; 2015; 15(9):751-61. PubMed ID: 25985952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.